Bomunity Ltd Co

FDA Regulatory Profile

Bomunity Ltd Co appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (F-0817-2021, Class II) was initiated on June 4, 2021.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
F-0817-2021Class IIPaximune Dietary Supplement Contains Bovine Proteins that help Promote Health and help Modulate ImmuJune 4, 2021